These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 674830)

  • 1. Analysis and disposition of low dose oral propranolol.
    MacKichan JJ; Pyszczynski DR; Jusko WJ
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):531-8. PubMed ID: 674830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of propranolol, 4-hydroxypropranolol and propranolol glycol in human plasma.
    Schneck DW; Pritchard JF; Hayes AH
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):3-12. PubMed ID: 432438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T; Walle UK
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of naphthoxylactic and naphtoxyacetic acid in human plasma following propranolol administration.
    Pritchard F; Schneck D; Hayes A
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):279-86. PubMed ID: 461953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent disposition of oral propranolol in normal subjects.
    Mackichan JJ; Pyszczynski DR; Jusko WJ
    Biopharm Drug Dispos; 1980; 1(4):159-66. PubMed ID: 7448344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption kinetics of sublingually administered propranolol.
    Kates RE
    J Med; 1977; 8(6):393-402. PubMed ID: 272433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of propranolol: a review.
    Shand DG
    Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog.
    Christ DD; Walle UK; Oatis JE; Walle T
    Drug Metab Dispos; 1990; 18(1):1-4. PubMed ID: 1970766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.
    Evans GH; Nies AS; Shand DG
    J Pharmacol Exp Ther; 1973 Jul; 186(1):114-22. PubMed ID: 4198771
    [No Abstract]   [Full Text] [Related]  

  • 10. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.
    Kharasch ED; Hoffer C; Walker A; Sheffels P
    Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacological actions of a long-acting formulation of propranolol.
    Ohashi K; Ebihara A; Kondo K; Usami M
    Arzneimittelforschung; 1984; 34(4):507-12. PubMed ID: 6378211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of diltiazem versus cimetidine on propranolol metabolism.
    Tateishi T; Ohashi K; Fujimura A; Ebihara A
    J Clin Pharmacol; 1992 Dec; 32(12):1099-104. PubMed ID: 1487547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol kinetics: use of automated liquid chromatography.
    Divoll M; Greenblatt DJ; Arendt RM
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):457-60. PubMed ID: 6500761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL; Walker SE; Bowles SK
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model to describe myocardial drug disposition in the dog.
    Kates RE; Jaillon P
    J Pharmacol Exp Ther; 1980 Jul; 214(1):31-6. PubMed ID: 7391969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.
    Bai SA; Walle UK; Walle T
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary human pharmacokinetics of triletide.
    Repossini L
    Pharmatherapeutica; 1985; 4(3 Spec No):189-94. PubMed ID: 4059299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of distribution of di-propranolol in various organs and discrete brain areas of the rat.
    Bianchetti G; Elghozi JL; Gomeni R; Meyer P; Morselli PL
    J Pharmacol Exp Ther; 1980 Sep; 214(3):682-7. PubMed ID: 7400970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute alcohol administration on propranolol absorption.
    Grabowski BS; Cady WJ; Young WW; Emery JF
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):317-9. PubMed ID: 7429677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
    Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
    Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.